Amarin (AMRN) Could See Action on Takeover Report

Go back to Amarin (AMRN) Could See Action on Takeover Report

Amarin (AMRN) Shares Active as AstraZeneca (AZN) Tops Q3 Expectations

October 25, 2012 8:02 AM EDT

Amarin Corp Plc (NASDAQ: AMRN) shares are active in early trading Thursday as potential bidder AstraZeneca (NYSE: AZN) is holding its quarterly conference call following third-quarter 2012 results.

Investors are bullish given Astra reported better-than-expected earnings results,... More

New AstraZeneca boss 'planning to launch cash bid' for US biopharmaceutical group Amarin

AstraZeneca's new boss Pascal Soriot didn’t mess about when on his first day in the job he announced the suspension of the drugs group’s £2.8bn share buy-back programme...